Aiocd Awacs

Rediff.com » News » Aiocd Awacs

News for Aiocd Awacs

News
Business

With Covid surge, FabiFlu becomes most sold drug in India

Drugs that are used to treat Covid or used by people as immunity boosters have seen a jump in sales and, in turn, rankings, reports Sohini Das. IMAGE: A chemist displays the Fabiflu......

Prices of key Covid bulk drugs shoot up as demand rises

The API of Paracetamol, a fever and pain medication, has grown 25 per cent from Rs 450-480 per kg in December 2020 to Rs 580-600 per kg in April. When compared to the pre-Covid prices of December......

After showing signs of recovery, pharma sales dip in July

Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed. The domestic pharmaceutical industry clocked negligible growth of 0.2 per......

Pharma industry posts 51.5% growth in April sales

When compared to the domestic sales of April 2019, the growth is around 37 per cent. However, compared to the previous month (March), the growth is 18.4 per cent. IMAGE: Kindly note that this......

2 reasons why drug sales are in poor health

Overall slowdown in the economy and growing volumes of unbranded generic medicines in the domestic market are behind poor sales. Illustration: Uttam Ghosh/Rediff.com Sales volume of pharmaceutical......

Pharma industry bounces back to good health

In May, price growth for drugs was in negative territory at (-)1 per cent The pharmaceutical industry, after 12 months, bounced back to double-digit growth in May, clocking a 10.8 per cent......

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

In India, itolizumab, known by the brand name Alzumab, has been priced at Rs 8,000 per vial. Most patients require four vials for Covid-19 treatment, taking the cost of the therapy to Rs 32,000.......

Aiocd Awacs

News for Aiocd Awacs

With Covid surge, FabiFlu becomes most sold drug in India

Prices of key Covid bulk drugs shoot up as demand rises

After showing signs of recovery, pharma sales dip in July

Pharma industry posts 51.5% growth in April sales

2 reasons why drug sales are in poor health

Pharma industry bounces back to good health

Sales of Biocon's itolizumab surge as phase-4 clinical trials begin

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS